TrialLeukemia2023

Glasdegib plus intensive or non-intensive chemotherapy for untreated acute myeloid leukemia: results from the randomized, phase 3 BRIGHT AML 1019 trial.

Mikkael A Sekeres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.